GP0243D- X-linked hypophosphatemia (XLH) in the US and the UK

At Global Patients, in partnership with an independent market research agency, we are currently conducting a market research study with patients or patient affiliates identified as X-linked hypophosphatemia (XLH) patients to get an understanding about XLH impact on their quality of life. We would also want to understand patient/ patient affiliates thoughts on support needs from physicians on their respective treatment.
o Your participation in this study would involve a telephonic in-depth interview (TDI) using virtual screen share platform or a video- discussion lasting 30-60 minutes.
o The market research itself is strictly non promotional and the feedback gained will be used to develop understandings of XLH disease area and patient needs.
o In appreciation for your time, you will receive 150USD/110GBP

If you, or somebody you love, is interested in the study, please, contact us at

Join this Study
Are you already a member of Global Patients?

Share this Study!
Share on Facebook
Tweet about this on Twitter
Share on LinkedIn